AcelRx Pharmaceuticals, Inc. (ACRX): Price and Financial Metrics


AcelRx Pharmaceuticals, Inc. (ACRX)

Today's Latest Price: $1.55 USD

0.06 (-3.73%)

Updated Feb 21 12:00am

Add ACRX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ACRX Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for ACRX is -0.09 -- better than just 6.35% of US stocks.
  • ACRX's price/sales ratio is 65.25; that's higher than the P/S ratio of 96.95% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -9.02 for Acelrx Pharmaceuticals Inc; that's greater than it is for only 1.74% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Acelrx Pharmaceuticals Inc, a group of peers worth examining would be BIOL, IRIX, ELGX, PMD, and AXGN.
  • ACRX's SEC filings can be seen here. And to visit Acelrx Pharmaceuticals Inc's official web site, go to www.acelrx.com.
ACRX Daily Price Range
ACRX 52-Week Price Range

ACRX Stock Price Chart More Charts


ACRX Price/Volume Stats

Current price $1.55 52-week high $4.09
Prev. close $1.61 52-week low $1.48
Day low $1.54 Volume 862,500
Day high $1.63 Avg. volume 704,343
50-day MA $1.92 Dividend yield N/A
200-day MA $2.24 Market Cap 123.34M

AcelRx Pharmaceuticals, Inc. (ACRX) Company Bio


AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of acute pain. The company was founded in 2005 and is based in Redwood City, California.


ACRX Latest News Stream


Event/Time News Detail
Loading, please wait...

ACRX Latest Social Stream


Loading social stream, please wait...

View Full ACRX Social Stream

ACRX Price Returns

1-mo -11.43%
3-mo -14.84%
6-mo -26.19%
1-year -51.56%
3-year -50.00%
5-year -81.66%
YTD -26.54%
2019 -8.66%
2018 14.07%
2017 -22.12%
2016 -32.47%
2015 -42.79%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7896 seconds.